These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20590706)

  • 41. Sclerotherapy of varicose leg veins. Technique, indications and complications.
    Kern P
    Int Angiol; 2002 Jun; 21(2 Suppl 1):40-5. PubMed ID: 12515979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An unusual complication of facial sclerotherapy.
    Hoffman K
    Dermatol Surg; 2003 Apr; 29(4):423-4. PubMed ID: 12656827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
    Fisher DA
    Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404
    [No Abstract]   [Full Text] [Related]  

  • 45. [Echo-guided compression sclerotherapy using foam: an improvement in the treatment of varicose veins].
    Kockaert MA; de Roos KP; Neumann HA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1758-63. PubMed ID: 16948234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity.
    Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):407-13. PubMed ID: 20547080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of sclerotherapy in abnormal varicose hand veins.
    Duffy DM; Garcia C; Clark RE
    Plast Reconstr Surg; 1999 Oct; 104(5):1474-9; discussion 1480-1. PubMed ID: 10513934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcome of short-term compression after sclerotherapy for telangiectatic varicose veins.
    Bayer A; Kuznik N; Langan EA; Recke A; Recke AL; Faerber G; Kaschwich M; Kleemann M; Kahle B
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):435-443. PubMed ID: 32502730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
    Gibson K; Gunderson K
    Surg Clin North Am; 2018 Apr; 98(2):415-429. PubMed ID: 29502781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.
    Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M
    Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late stroke after foam sclerotherapy.
    Hahn M; Schulz T; Jünger M
    Vasa; 2010 Feb; 39(1):108-10. PubMed ID: 20186684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.
    Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
    J Vasc Surg; 2008 Apr; 47(4):830-6. PubMed ID: 18242937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Eckmann DM; Kobayashi S
    J Vasc Surg; 2006 Jul; 44(1):225; author reply 225-6. PubMed ID: 16828455
    [No Abstract]   [Full Text] [Related]  

  • 56. Sclerotherapy: it is back and better.
    Mann MW
    Clin Plast Surg; 2011 Jul; 38(3):475-87, vii. PubMed ID: 21824544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatocele.
    Jahnson S; Sandblom D; Holmäng S
    J Urol; 2011 Oct; 186(4):1319-23. PubMed ID: 21849198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurological complications of sclerotherapy for varicose veins.
    Sarvananthan T; Shepherd AC; Willenberg T; Davies AH
    J Vasc Surg; 2012 Jan; 55(1):243-51. PubMed ID: 21840152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regarding "Stroke after varicose vein foam injection sclerotherapy".
    Morrison N; Cavezzi A; Bergan J; Partsch H
    J Vasc Surg; 2006 Jul; 44(1):224-5; author reply 225-6. PubMed ID: 16828453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.